Table 2 Baseline blood pressure and changes in clinic and ABPM of SBP/DBP after 24 weeks of treatment

From: Antihypertensive efficacy of the angiotensin receptor blocker azilsartan medoxomil compared with the angiotensin-converting enzyme inhibitor ramipril

LS mean (s.e.)

AZL-M 40

AZL-M 80

RAM 10

 

SBP

DBP

SBP

DBP

SBP

DBP

Baseline clinic BP

160.9±0.5

94.8±0.5

161.5±0.5

95.7±0.5

161.4±0.5

94.6±0.5

Change from BL to week 24

−20.6±0.9

−10.2±0.6

−21.2±0.9

−10.5±0.6

−12.2±0.9

−4.9±0.6

Baseline 24-h mean ABPM

140.7±1.0

86.4±0.8

139.5±1.0

86.0±0.7

141.0±1.0

86.7±0.8

Change from BL to week 24

 24-h mean

−12.7±1.0

−8.0±0.7

−12.3±1.0

−8.3±0.6

−7.8±1.0

−5.3±0.7

 Mean daytime (0600–2200 hours)

−12.6±1.0

−8.2±0.7

−12.4±1.0

−8.5±0.7

−8.1±1.1

−5.6±0.7

 Mean nighttime (0000–0600 hours)

−12.8±1.1

−7.4±0.8

−12.7±1.1

−8.2±0.8

−6.9±1.1

−4.4±0.8

 Mean trough (22–24 h)

−15.6±1.2

−10.2±0.9

−14.9±1.2

−9.9±0.9

−6.7±1.2

−4.5±0.9

  1. Abbreviations: ABPM, ambulatory blood pressure monitoring; AZL-M, azilsartan medoxomil; BL, baseline; DBP, diastolic blood pressure; LS, least square; RAM, ramipril; SBP, systolic blood pressure.
  2. AZL-M vs RAM: P<0.05 for all comparisons.